Adverse effects of testosterone therapy in adult men: A systematic review and meta-analysis

Journal of Clinical Endocrinology and Metabolism

Volumn 95, Issue 6, 2010, Pages 2560-2575

  Fernández Balsells, M Mercè ^a,b   Murad, Mohammad Hassan ^a   Lane, Melanie ^a   Lampropulos, Juliana F ^a   Albuquerque, Felipe ^a   Mullan, Rebecca J ^a   Agrwal, Neera ^a,c   Elamin, Mohamed B ^a   Gallegos Orozco, Juan F ^a,c   Wang, Amy T ^a   Erwin, Patricia J ^a   Bhasin, Shalender ^d   Montori, Victor M ^a  

^a MAYO CLINIC   (United States)

^b HOSPITAL JOSEP TRUETA   (Spain)

^c MAYO CLINIC   (United States)

^d BOSTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

HEMOGLOBIN; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; TESTOSTERONE; TESTOSTERONE ENANTATE; TESTOSTERONE ESTER; TESTOSTERONE UNDECANOATE;

ANDROGEN THERAPY; CANCER RISK; CARDIOVASCULAR RISK; CHOLESTEROL BLOOD LEVEL; CLINICAL TRIAL; DRUG DOSAGE FORM COMPARISON; DRUG DOSE COMPARISON; DRUG SAFETY; ERYTHROCYTOSIS; HEART ARRHYTHMIA; HEART INFARCTION; HEART MUSCLE REVASCULARIZATION; HEMATOCRIT; HEMOGLOBIN BLOOD LEVEL; HUMAN; LOWER URINARY TRACT SYMPTOM; MALE; META ANALYSIS; MORTALITY; OUTCOME ASSESSMENT; PRIORITY JOURNAL; PROSTATE CANCER; REVIEW; SENSITIVITY ANALYSIS; SIDE EFFECT; SYSTEMATIC REVIEW; TREATMENT DURATION; TREATMENT INDICATION; ADULT; CARDIOVASCULAR DISEASE; CHEMICALLY INDUCED DISORDER; METHODOLOGY; POLYCYTHEMIA; PROSTATE TUMOR; RANDOMIZED CONTROLLED TRIAL; RISK FACTOR; STANDARD; STATISTICAL ANALYSIS; TREATMENT OUTCOME; URINARY TRACT DISEASE;

ADULT; CARDIOVASCULAR DISEASES; DATA INTERPRETATION, STATISTICAL; HUMANS; MALE; MORTALITY; POLYCYTHEMIA; PROSTATIC NEOPLASMS; RANDOMIZED CONTROLLED TRIALS AS TOPIC; RESEARCH DESIGN; RISK FACTORS; TESTOSTERONE; TREATMENT OUTCOME; UROLOGIC DISEASES;

EID: 77954394453     PISSN: 0021972X     EISSN: 0021972X     Source Type: Journal    
DOI: 10.1210/jc.2009-2575     Document Type: Review

References (72)

1. Harman SM, Metter EJ, Tobin JD, Pearson J, Blackman MR 2001 Longitudinal effects of aging on serum total and free testosterone levels in healthy men. Baltimore Longitudinal Study of Aging. J Clin Endocrinol Metab 86:724-731
2. Isidori AM, Giannetta E, Gianfrilli D, Greco EA, Bonifacio V, Aversa A, Isidori A, Fabbri A, Lenzi A 2005 Effects of testosterone on sexual function in men: results of a meta-analysis. Clin Endocrinol (Oxf) 63:381-394
3. Ottenbacher KJ, Ottenbacher ME, Ottenbacher AJ, Acha AA, Ostir GV 2006 Androgen treatment and muscle strength in elderly men: a meta-analysis. J Am Geriatr Soc 54:1666-1673
4. Isidori AM, Giannetta E, Greco EA, Gianfrilli D, Bonifacio V, Isidori A, Lenzi A, Fabbri A 2005 Effects of testosterone on body composition, bone metabolism and serum lipid profile in middle-aged men: a meta-analysis. Clin Endocrinol (Oxf) 63:280-293
5. Boloña ER, Uraga MV, Haddad RM, Tracz MJ, Sideras K, Kennedy CC, Caples SM, Erwin PJ, Montori VM 2007 Testosterone use in men with sexual dysfunction: a systematic review and meta-analysis of randomized placebo-controlled trials. Mayo Clin Proc 82:20-28 (Pubitemid 46036318)
6. Calof OM, Singh AB, Lee ML, Kenny AM, Urban RJ, Tenover JL, Bhasin S 2005 Adverse events associated with testosterone replacement in middle-aged and older men: a meta-analysis of randomized, placebo-controlled trials. J Gerontol A Biol Sci Med Sci 60:1451-1457 (Pubitemid 41798454)
7. Haddad RM, Kennedy CC, Caples SM, Tracz MJ, Boloña ER, Sideras K, Uraga MV, Erwin PJ, Montori VM 2007 Testosterone and cardiovascular risk in men: a systematic review and meta-analysis of randomized placebo-controlled trials. Mayo Clin Proc 82:29-39 (Pubitemid 46036319)
8. Basu R, Dalla Man C, Campioni M, Basu A, Nair KS, Jensen MD, Khosla S, Klee G, Toffolo G, Cobelli C, Rizza RA 2007 Effect of 2 years of testosterone replacement on insulin secretion, insulin action, glucose effectiveness, hepatic insulin clearance, and postprandial glucose turnover in elderly men. Diabetes Care 30:1972-1978
9. Kapoor D, Goodwin E, Channer KS, Jones TH 2006 Testosterone replacement therapy improves insulin resistance, glycaemic control, visceral adiposity and hypercholesterolaemia in hypogonadal men with type 2 diabetes. Eur J Endocrinol 154:899-906
10. Marks LS, Mazer NA, Mostaghel E, Hess DL, Dorey FJ, Epstein JI, Veltri RW, Makarov DV, Partin AW, Bostwick DG, Macairan ML, Nelson PS 2006 Effect of testosterone replacement therapy on prostate tissue in men with late-onset hypogonadism: a randomized controlled trial. JAMA 296:2351-2361
11. Nair KS, Rizza RA, O'Brien P, Dhatariya K, Short KR, Nehra A, Vittone JL, Klee GG, Basu A, Basu R, Cobelli C, Toffolo G, Dalla Man C, Tindall DJ, Melton 3rd LJ, Smith GE, Khosla S, Jensen MD 2006 DHEA in elderly women and DHEA or testosterone in elderly men. N Engl J Med 355:1647-1659
12. Malkin CJ, Pugh PJ, West JN, van Beek EJ, Jones TH, Channer KS 2006 Testosterone therapy in men with moderate severity heart failure: a double-blind randomized placebo controlled trial. Eur Heart J 27:57-64
13. Moher D, Liberati A, Tetzlaff J, Altman DG, Prisma Group 2009 Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. PLoS Med 6:e1000097
14. Swiglo BA, Murad MH, Schünemann HJ, Kunz R, Vigersky RA, Guyatt GH, Montori VM 2008 A case for clarity, consistency, and helpfulness: state-of-the-art clinical practice guidelines in endocrinology using the grading of recommendations, assessment, development, and evaluation system. J Clin Endocrinol Metab 93:666-673
15. DerSimonian R, Laird N 1986 Meta-analysis in clinical trials. Controlled Clinical Trials 7:177-188
16. Higgins JP, Thompson SG, Deeks JJ, Altman DG 2003 Measuring inconsistency in meta-analyses. BMJ 327:557-560
17. Allan CA, Strauss BJ, Burger HG, Forbes EA, McLachlan RI 2008 Testosterone therapy prevents gain in visceral adipose tissue and loss of skeletal muscle in nonobese aging men. J Clin Endocrinol Metab 93:139-146
18. Chiang HS, Hwang TI, Hsui YS, Lin YC, Chen HE, Chen GC, Liao CH 2007 Transdermal testosterone gel increases serum testosterone levels in hypogonadal men in Taiwan with improvements in sexual function. Int J Impot Res 19:411-417
19. Snyder PJ, Peachey H, Berlin JA, Rader D, Usher D, Loh L, Hannoush P, Dlewati A, Holmes JH, Santanna J, Strom BL 2001 Effect of transdermal testosterone treatment on serum lipid and apolipoprotein levels in men more than 65 years of age. Am J Med 111:255-260
20. Steidle C, Schwartz S, Jacoby K, Sebree T, Smith T, Bachand R 2003 AA2500 testosterone gel normalizes androgen levels in aging males with improvements in body composition and sexual function. J Clin Endocrinol Metab 88:2673-2681 (Pubitemid 36724441)
21. Wittert GA, Chapman IM, Haren MT, Mackintosh S, Coates P, Morley JE 2003 Oral testosterone supplementation increases muscle and decreases fat mass in healthy elderly males with low-normal gonadal status. J Gerontol A Biol Sci Med Sci 58:618-625 (Pubitemid 36900168)
22. Furukawa TA, Watanabe N, Omori IM, Montori VM, Guyatt GH 2007 Association between unreported outcomes and effect size estimates in Cochrane meta-analyses. JAMA 297:468-470
23. Petak SM, Nankin HR, Spark RF, Swerdloff RS, Rodriguez-Rigau LJ 2002 American Association of Clinical Endocrinologists Medical Guidelines for clinical practice for the evaluation and treatment of hypogonadism in adult male patients-2002 update. Endocr Pract 8:440-456
24. Agledahl I, Hansen JB, Svartberg J 2008 Impact of testosterone treatment on postprandial triglyceride metabolism in elderly men with subnormal testosterone levels. Scand J Clin Lab Invest 68:641-648
25. Amory JK, Watts NB, Easley KA, Sutton PR, Anawalt BD, Matsumoto AM, Bremner WJ, Tenover JL 2004 Exogenous testosterone or testosterone with finasteride increases bone mineral density in older men with low serum testosterone. J Clin Endocrinol Metab 89:503-510
26. Page ST, Amory JK, Bowman FD, Anawalt BD, Matsumoto AM, Bremner WJ, Tenover JL 2005 Exogenous testosterone (T) alone or with finasteride increases physical performance, grip strength, and lean body mass in older men with low serum T. J Clin Endocrinol Metab 90:1502-1510
27. Basurto L, Zarate A, Gomez R, Vargas C, Saucedo R, Galván R 2008 Effect of testosterone therapy on lumbar spine and hip mineral density in elderly men. Aging Male 11:140-145
28. Bhasin S, Storer TW, Asbel-Sethi N, Kilbourne A, Hays R, Sinha-Hikim I, Shen R, Arver S, Beall G 1998 Effects of testosterone replacement with a nongenital, transdermal system, Androderm, in human immunodeficiency virus-infected men with low testosterone levels. J Clin Endocrinol Metab 83:3155-3162
29. Bhasin S, Storer TW, Javanbakht M, Berman N, Yarasheski KE, Phillips J, Dike M, Sinha-Hikim I, Shen R, Hays RD, Beall G 2000 Testosterone replacement and resistance exercise in HIV-infected men with weight loss and low testosterone levels. [See comment] JAMA 283:763-770
30. Bhasin S, Parker RA, Sattler F, Haubrich R, Alston B, Umbleja T, Shikuma CM, Team ACTGPAS 2007 Effects of testosterone supplementation on whole body and regional fat mass and distribution in human immunodeficiency virus-infected men with abdominal obesity. J Clin Endocrinol Metab 92:1049-1057
31. Blackman MR, Sorkin JD, Münzer T, Bellantoni MF, Busby-Whitehead J, Stevens TE, Jayme J, O'Connor KG, Christmas C, Tobin JD, Stewart KJ, Cottrell E, St Clair C, Pabst KM, Harman SM 2002 Growth hormone and sex steroid administration in healthy aged women and men: a randomized controlled trial. JAMA 288:2282-2292 (Pubitemid 35291758)
32. Christmas C, O'Connor KG, Harman SM, Tobin JD, Münzer T, Bellantoni MF, Clair CS, Pabst KM, Sorkin JD, Blackman MR 2002 Growth hormone and sex steroid effects on bone metabolism and bone mineral density in healthy aged women and men. J Gerontol A Biol Sci Med Sci 57:M12-M18 (Pubitemid 34074441)
33. Boyanov MA, Boneva Z, Christov VG 2003 Testosterone supplementation in men with type 2 diabetes, visceral obesity and partial androgen deficiency. Aging Male 6:1-7 (Pubitemid 36606394)
34. Brockenbrough AT, Dittrich MO, Page ST, Smith T, Stivelman JC, Bremner WJ 2006 Transdermal androgen therapy to augment EPO in the treatment of anemia of chronic renal disease. Am J Kidney Dis 47:251-262
35. Cavallini G, Caracciolo S, Vitali G, Modenini F, Biagiotti G 2004 Carnitine versus androgen administration in the treatment of sexual dysfunction, depressed mood, and fatigue associated with male aging. Urology 63:641-646
36. Clague JE, Wu FC, Horan MA 1999 Difficulties in measuring the effect of testosterone replacement therapy on muscle function in older men. Int J Androl 22:261-265
37. Coodley GO, Coodley MK 1997 A trial of testosterone therapy for HIV-associated weight loss. AIDS 11:1347-1352
38. 1986 Testosterone treatment of men with alcoholic cirrhosis: a double-blind study. The Copenhagen Study Group for Liver Diseases. Hepatology 6:807-813
39. Drinka PJ, Jochen AL, Cuisinier M, Bloom R, Rudman I, Rudman D1995 Polycythemia as a complication of testosterone replacement therapy in nursing home men with low testosterone levels. J Am Geriatr Soc 43:899-901
40. English KM, Steeds RP, Jones TH, Diver MJ, Channer KS 2000 Low-dose transdermal testosterone therapy improves angina threshold in men with chronic stable angina: a randomized, doubleblind, placebo-controlled study. Circulation 102:1906-1911
41. Ferrando AA, Sheffield-Moore M, Paddon-Jones D, Wolfe RR, Urban RJ 2003 Differential anabolic effects of testosterone and amino acid feeding in older men. J Clin Endocrinol Metab 88:358-362
42. Ferrando AA, Sheffield-Moore M, Yeckel CW, Gilkison C, Jiang J, Achacosa A, Lieberman SA, Tipton K, Wolfe RR, Urban RJ 2002 Testosterone administration to older men improves muscle function: molecular and physiological mechanisms. Am J Physiol Endocrinol Metab 282:E601-E607
43. Giannoulis MG, Sonksen PH, Umpleby M, Breen L, Pentecost C, Whyte M, McMillan CV, Bradley C, Martin FC 2006 The effects of growth hormone and/or testosterone in healthy elderly men: a randomized controlled trial. J Clin Endocrinol Metab 91:477-484
44. Grinspoon S, Corcoran C, Askari H, Schoenfeld D, Wolf L, Burrows B, Walsh M, Hayden D, Parlman K, Anderson E, Basgoz N, Klibanski A 1998 Effects of androgen administration in men with the AIDS wasting syndrome. A randomized, double-blind, placebocontrolled trial. Ann Intern Med 129:18-26
45. Grinspoon S, Corcoran C, Anderson E, Hubbard J, Stanley T, Basgoz N, Klibanski A 1999 Sustained anabolic effects of long-term androgen administration in men with AIDS wasting. Clin Infect Dis 28:634-636 (Pubitemid 29242546)
46. Grinspoon S, Corcoran C, Parlman K, Costello M, Rosenthal D, Anderson E, Stanley T, Schoenfeld D, Burrows B, Hayden D, Basgoz N, Klibanski A 2000 Effects of testosterone and progressive resistance training in eugonadal men with AIDS wasting. A randomized, controlled trial. [See comment] Ann Intern Med 133:348-355
47. Howell SJ, Radford JA, Adams JE, Smets EM, Warburton R, Shalet SM 2001 Randomized placebo-controlled trial of testosterone replacement in men with mild Leydig cell insufficiency following cytotoxic chemotherapy. Clin Endocrinol (Oxf) 55:315-324
48. Katznelson L, Robinson MW, Coyle CL, Lee H, Farrell CE 2006 Effects of modest testosterone supplementation and exercise for 12 weeks on body composition and quality of life in elderly men. Eur J Endocrinol 155:867-875
49. Kenny AM, Prestwood KM, Gruman CA, Fabregas G, Biskup B, Mansoor G 2002 Effects of transdermal testosterone on lipids and vascular reactivity in older men with low bioavailable testosterone levels. J Gerontol A Biol Sci Med Sci 57:M460-M465 (Pubitemid 34733814)
50. Kenny AM, Fabregas G, Song C, Biskup B, Bellantonio S 2004 Effects of testosterone on behavior, depression, and cognitive function in older men with mild cognitive loss. J Gerontol A Biol Sci Med Sci 59:75-78
51. Knapp PE, Storer TW, Herbst KL, Singh AB, Dzekov C, Dzekov J, LaValley M, Zhang A, Ulloor J, Bhasin S 2008 Effects of a supraphysiological dose of testosterone on physical function, muscle performance, mood, and fatigue in men with HIV-associated weight loss. Am J Physiol Endocrinol Metab 294:E1135-E1143
52. Mårin P, Holmäng S, Jönsson L, Sjöström L, Kvist H, Holm G, Lindstedt G, Björntorp P 1992 The effects of testosterone treatment on body composition and metabolism in middle-aged obese men. Int J Obes Relat Metab Disord 16:991-997
53. Merza Z, Blumsohn A, Mah PM, Meads DM, McKenna SP, Wylie K, Eastell R, Wu F, Ross RJ 2006 Double-blind placebo-controlled study of testosterone patch therapy on bone turnover in men with borderline hypogonadism. Int J Androl 29:381-391
54. Morley JE, Perry 3rd HM, Kaiser FE, Kraenzle D, Jensen J, Houston K, Mattammal M, Perry Jr HM 1993 Effects of testosterone replacement therapy in old hypogonadal males: a preliminary study. J Am Geriatr Soc 41:149-152
55. Reid IR, Wattie DJ, Evans MC, Stapleton JP 1996 Testosterone therapy in glucocorticoid-treated men. Arch Intern Med 156:1173-1177
56. Sih R, Morley JE, Kaiser FE, Perry 3rd HM, Patrick P, Ross C 1997 Testosterone replacement in older hypogonadal men: a 12-month randomized controlled trial. J Clin Endocrinol Metab 82:1661-1667
57. Simon D, Charles MA, Lahlou N, Nahoul K, Oppert JM, Gouault-Heilmann M, Lemort N, Thibult N, Joubert E, Balkau B, Eschwege E 2001 Androgen therapy improves insulin sensitivity and decreases leptin level in healthy adult men with low plasma total testosterone: a 3-month randomized placebo-controlled trial. Diabetes Care 24:2149-2151
58. Snyder PJ, Peachey H, Hannoush P, Berlin JA, Loh L, Holmes JH, Dlewati A, Staley J, Santanna J, Kapoor SC, Attie MF, Haddad Jr JG, Strom BL 1999 Effect of testosterone treatment on bone mineral density in men over 65 years of age. J Clin Endocrinol Metab 84:1966-1972 (Pubitemid 30647018)
59. Snyder PJ, Peachey H, Hannoush P, Berlin JA, Loh L, Lenrow DA, Holmes JH, Dlewati A, Santanna J, Rosen CJ, Strom BL 1999 Effect of testosterone treatment on body composition and muscle strength in men over 65 years of age. J Clin Endocrinol Metab 84:2647-2653 (Pubitemid 30641987)
60. Sullivan DH, Roberson PK, Johnson LE, Bishara O, Evans WJ, Smith ES, Price JA 2005 Effects of muscle strength training and testosterone in frail elderly males. Med Sci Sports Exerc 37:1664-1672
61. Svartberg J, Aasebø U, Hjalmarsen A, Sundsfjord J, Jorde R 2004 Testosterone treatment improves body composition and sexual function in men with COPD, in a 6-month randomized controlled trial. Respir Med 98:906-913 (Pubitemid 39069342)
62. Tan RS, Pu SJ 2003 A pilot study on the effects of testosterone in hypogonadal aging male patients with Alzheimer's disease. Aging Male 6:13-17
63. Dobs AS, Cofrancesco J, Nolten WE, Danoff A, Anderson R, Hamilton CD, Feinberg J, Seekins D, Yangco B, Rhame F 1999 The use of a transscrotal testosterone delivery system in the treatment of patients with weight loss related to human immunodeficiency virus infection. Am J Med 107:126-132
64. Dohn K, Hvidt V, Nielsen J, Palm L 1968 Testosterone therapy in obliterating arterial lesions in the lower limbs. Angiology 19:342-350
65. Hall GM, Larbre JP, Spector TD, Perry LA, Da Silva JA 1996 A randomized trial of testosterone therapy in males with rheumatoid arthritis. Br J Rheumatol 35:568-573 (Pubitemid 126719489)
66. Hentzer E, Madsen PC 1967 Testosterone in the treatment of arterial insufficiency of the lower limbs. Scand J Clin Lab Invest Suppl 99:198-206
67. Pugh PJ, Jones RD, West JN, Jones TH, Channer KS 2004 Testosterone treatment for men with chronic heart failure. Heart 90:446-447 (Pubitemid 38406925)
68. Harman SM, Blackman MR 2003 The effects of growth hormone and sex steroid on lean body mass, fat mass, muscle strength, cardiovascular endurance and adverse events in healthy elderly women and men. Horm Res 60(Suppl 1):121-124
69. Münzer T, Harman SM, Hees P, Shapiro E, Christmas C, Bellantoni MF, Stevens TE, O'Connor KG, Pabst KM, St Clair C, Sorkin JD, Blackman MR 2001 Effects of GH and/or sex steroid administration on abdominal subcutaneous and visceral fat in healthy aged women and men. J Clin Endocrinol Metab 86:3604-3610
70. Crawford BA, Liu PY, Kean MT, Bleasel JF, Handelsman DJ 2003 Randomized placebo-controlled trial of androgen effects on muscle and bone in men requiring long-term systemic glucocorticoid treatment. J Clin Endocrinol Metab 88:3167-3176
71. Emmelot-Vonk MH, Verhaar HJ, Nakhai Pour HR, Aleman A, Lock TM, Bosch JL, Grobbee DE, van der Schouw YT 2008 Effect of testosterone supplementation on functional mobility, cognition, and other parameters in older men: a randomized controlled trial. JAMA 299:39-52
72. Gold J, Batterham MJ, Rekers H, Harms MK, Geurts TB, Helmyr PM, Silva de Mendonça J, Falleiros Carvalho LH, Panos G, Pinchera A, Aiuti F, Lee C, Horban A, Gatell J, Phanuphak P, Prasithsirikul W, Gazzard B, Bloch M, Danner SA 2006 Effects of nandrolone decanoate compared with placebo or testosterone on HIV-associated wasting. HIV Med 7:146-155